Navigating the Use of Extracellular Vesicles as Therapeutics

Listicle

Published: February 8, 2022

Michele Trott, PhD

Navigating the Use of Extracellular Vesicles as Therapeutics content piece image

To explore and expand options for drug delivery, many are looking to extracellular vesicles (EVs) for their potential as drug encapsulation platforms and vaccine vehicles. EVs are a diverse group of naturally occurring nanoparticles released by cells and possess many characteristics which make them attractive diagnostic and therapeutic candidates.

Download this listicle to learn more about EVs:

As engineerable drug delivery vehicles
As vaccines
From mesenchymal stem cells

Meet the Author

Michele Trott, PhD

Michele Trott holds a PhD in endocrinology from Lincoln University. She works as a freelance science writer and scientific content manager for Izon Science.